Phase III RESONATE-2: Frontline Ibrutinib vs Chlorambucil in Elderly Patients With CLL

Slideset - In this phase III trial that enrolled elderly treatment-naive patients with CLL, ibrutinib was associated with significant reductions in risk of progression and death vs chlorambucil.

Source: Clinical Care Options Leukemia - December 12, 2015 Category: Hematology Source Type: research